share_log

Morgan Stanley Reiterates Equal-Weight on Amicus Therapeutics, Maintains $15 Price Target

Morgan Stanley Reiterates Equal-Weight on Amicus Therapeutics, Maintains $15 Price Target

摩根士丹利重申對Amicus Therapeutics的同等權重,維持15美元的目標股價
Benzinga ·  2023/07/11 08:57

Morgan Stanley analyst Andrew Galler reiterates Amicus Therapeutics (NASDAQ:FOLD) with a Equal-Weight and maintains $15 price target.

摩根士丹利分析師安德魯·蓋勒重申了Amicus Therapeutics(納斯達克股票代碼:FOLD)的權重相當,並維持15美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論